Company Name:Xencor Inc.
CEO: Bassil I. Dahiyat

Sector: Healthcare
Industry:Biotechnology

Exchange: NASDAQ Global Market

Country: USA

Description: Xencor Inc is engaged in the field of biotechnology. The United States-based firm develops drugs to combat severe diseases such as allergies and cancers.


Key numbers

Market Capitalization:2129873550
Shares Outstanding: 56721000
Float: 56185610
Next Earning Date:2020-02-25
TTm EPS: 0.6333
TTm Dividend Rate:
200 days moving average:36.49
50 days moving average: 37.2
One day percent Change: -2.64



2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,